Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Perspective Therapeutics, Inc. Director's Dealing 2008

May 21, 2008

33510_dirs_2008-05-21_af9767db-8685-4454-8001-faa5778018fb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2008-05-19

Reporting Person: Woods Lori A (Acting COO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-05-19 Common Stock P 3664 $0.9 Acquired 6664 Direct
2008-05-19 Common Stock P 1336 $0.8997 Acquired 8000 Direct